Home > Press > Paper Published on Keystone Nano’s Ceramide Nanoliposome Program
 |
Abstract:
Keystone Nano is pleased to announce the publication of a manuscript describing the preclinical development of the company’s lead product, the Ceramide Nanoliposome (CNL). This product is designed to more effectively treat cancer by providing selectively killing cancer cells without harming normal cells. The paper was published in June 2015 issue of Biological Chemistry and authored by Dr. Mylisa Parette, Keystone Nano’s Research Manager, Dr. Mark Kester, Keystone Nano’s Chief Medical Officer, Ms. Jocelyn Bassler, Keystone Nano Research Chemist, Dr. Carly Carter, Keystone Research Team Leader and Mr. Jeff Davidson, Keystone Nano’s CEO. Also contributing was Dr. Todd Fox of the University of Virginia.
Paper Published on Keystone Nano’s Ceramide Nanoliposome Program
State College, PA | Posted on June 11th, 2015Keystone Nano is currently compiling an Investigational New Drug filing on the Ceramide Nanoliposome for review by the US Food and Drug Administration. The company anticipates that the initial clinical trial will treat patients with a range of cancers. After this initial testing is complete, the company anticipates enrolling in clinical testing patients with Liver Cancer or other difficult to treat cancers.
####
About Keystone Nano
Based in State College, Keystone Nano is working at the interface between nanotechnology and the life sciences and has licensed intellectual property around nanoparticles from Penn State University and is further developing this technology. The company is working to commercialize NanoJacket products and Nanoliposomes for a variety of medical applications.
For more information about Keystone Nano, visit our website keystonenano.com or follow us on twitter @keystonenano.
For more information, please click here
Contacts:
Jeff Davidson
CEO
814-466-5080
Dr. Mylisa Parette
Research Manager
814-237-4657
Copyright © Keystone Nano
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Bookmark:
| Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Cancer
The mechanism of a novel circular RNA circZFR that promotes colorectal cancer progression July 5th, 2024
New micromaterial releases nanoparticles that selectively destroy cancer cells April 5th, 2024
Govt.-Legislation/Regulation/Funding/Policy
New discovery aims to improve the design of microelectronic devices September 13th, 2024
Physicists unlock the secret of elusive quantum negative entanglement entropy using simple classical hardware August 16th, 2024
Single atoms show their true color July 5th, 2024
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Patents/IP/Tech Transfer/Licensing
Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023
Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021
Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||